Vitamin D and Type 2 Diabetes Study (D2d Study)

The purpose of this study was to evaluate the effect of taking vitamin D supplements on the prevention of diabetes in people who are at high risk for diabetes. D2d was a multi-center trial and enrolled over 2,400 participants.

Eligible Participants

Eligible participants for this study met the following criteria:

  • Both men and women
  • 30 years of age or older
  • Has prediabetes (“borderline” diabetes)
  • Were willing to be randomly assigned to take either a vitamin D supplement (4000 international units) or a placebo for roughly 4 years

Study Design

Participation in the study required up to 13 scheduled visits to the Clinical Translational Unit (CTRU) at Stanford Hospital & Clinics, which included blood draws at certain time points.


Among people at high risk for type 2 diabetes, vitamin D3 supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. The results of this study were published in the New England Journal of Medicine in August, 2019.

Stanford Prevention Research Center

In the News: